NEW YORK (GenomeWeb News) – A group of Canadian research institutes, universities, and funding partners have launched a C$8.2 million (US$8 million) effort to conduct molecular and genomic studies of glioblastoma tumors and develop targeted, personalized treatments for the deadly brain cancer, the Terry Fox Research Institute said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.